Systane® Hydration PF and Systane® Hydration Preserved - Trial NCT05932238
Access comprehensive clinical trial information for NCT05932238 through Pure Global AI's free database. This phase not specified trial is sponsored by Alcon Research and is currently Not yet recruiting. The study focuses on Dry Eye. Target enrollment is 135 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Polyethylene glycol 400 and propylene glycol solution/drops - Preservative Free (PF)
Interventional
other
Sponsor & Location
Alcon Research
Timeline & Enrollment
N/A
Sep 01, 2023
May 01, 2024
Primary Outcome
Mean overall IDEEL-Symptom Bother(SB) score - Group 1,Resultant overall CLDEQ-8 score - Group 2 and Group 3
Summary
The purpose of this post-market clinical follow-up (PMCF) study is to assess the performance
 and safety of Systane Hydration Preservative Free (PF) in subjects experiencing dry eye
 symptoms (Group 1) and in contact lens (CL) wearers experiencing discomfort due to CL-related
 dryness (Group 2) and also Systane Hydration Preserved in CL wearers experiencing discomfort
 due to CL-related dryness (Group 3). Statistical analyses will be presented by group.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05932238
Non-Device Trial